Bivariate analysis | Non-atopic participants (n = 54) | Atopic participants (n = 23) | ||||
---|---|---|---|---|---|---|
 | β | p | 95% CI | β | p | 95% CI |
MMRC (dyspnea) | 0.11 | 0.31 | [−0.11,0.33] | 0.21 | 0.01 | [0.06,0.37] |
Rescue medication use | 0.06 | 0.49 | [−0.11,0.24] | 0.18 | 0.03 | [0.02,0.34] |
BCSS | −0.28 | 0.13 | [−0.65,0.09] | 0.32 | 0.09 | [−0.05,0.69] |
SGRQ | 1.04 | 0.47 | [−1.77,3.85] | 2.15 | 0.05 | [0.03,4.27] |
 | OR | p | 95% CI | OR | p | 95% CI |
Wheeze | 1.38 | 0.14 | [0.90,2.11] | 2.25 | 0.01 | [1.22,4.14] |
Nocturnal symptoms | 1.00 | 0.98 | [0.55,1.80] | 1.76 | 0.04 | [1.02,3.01] |
Cough | 0.76 | 0.27 | [0.46,1.24] | 1.11 | 0.50 | [0.82,1.51] |
Phlegm | 1.09 | 0.67 | [0.72,1.66] | 1.15 | 0.37 | [0.84,1.57] |
Severe exacerbations | 0.89 | 0.81 | (0.35, 2.28) | 1.27 | 0.21 | (0.87, 1.83) |